312 related articles for article (PubMed ID: 15990455)
1. Oral testosterone in male rats and the development of experimental autoimmune encephalomyelitis.
Macció DR; Calfa G; Roth GA
Neuroimmunomodulation; 2005; 12(4):246-54. PubMed ID: 15990455
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide mediates the suppressive effect of testosterone on cell proliferative response to myelin basic protein.
Macció DR; Fozzatti L; Ditamo Y; Masini-Repiso AM; Roth GA
J Neuroimmunol; 2008 Aug; 199(1-2):63-6. PubMed ID: 18579221
[TBL] [Abstract][Full Text] [Related]
3. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
[TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
Higgins PJ; Weiner HL
J Immunol; 1988 Jan; 140(2):440-5. PubMed ID: 2447178
[TBL] [Abstract][Full Text] [Related]
5. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats.
Mannie MD; Dinarello CA; Paterson PY
J Immunol; 1987 Jun; 138(12):4229-35. PubMed ID: 2438337
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
8. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation.
Maña P; Fordham SA; Staykova MA; Correcha M; Silva D; Willenborg DO; Liñares D
J Neuroimmunol; 2009 May; 210(1-2):13-21. PubMed ID: 19344958
[TBL] [Abstract][Full Text] [Related]
9. Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats.
Quintanar-Stephano A; Chavira-Ramírez R; Kovacs K; Berczi I
J Endocrinol; 2005 Jan; 184(1):51-8. PubMed ID: 15642782
[TBL] [Abstract][Full Text] [Related]
10. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
Meyer AL; Benson JM; Gienapp IE; Cox KL; Whitacre CC
J Immunol; 1996 Nov; 157(9):4230-8. PubMed ID: 8892661
[TBL] [Abstract][Full Text] [Related]
11. Serum testosterone and corticosterone levels in acute experimental autoimmune encephalomyelitis (EAE) in male Wistar rats.
Macció DR; Calfa G; Volosín M; Roth GA
Neuro Endocrinol Lett; 2004 Jun; 25(3):196-200. PubMed ID: 15349085
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visna.
Panitch H; Petursson G; Georgsson G; Palsson PA; Nathanson N
Lab Invest; 1976 Nov; 35(5):452-60. PubMed ID: 186662
[TBL] [Abstract][Full Text] [Related]
13. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
Korn T; Magnus T; Toyka K; Jung S
J Leukoc Biol; 2004 Nov; 76(5):950-60. PubMed ID: 15328336
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
15. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
16. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Dalal M; Kim S; Voskuhl RR
J Immunol; 1997 Jul; 159(1):3-6. PubMed ID: 9200430
[TBL] [Abstract][Full Text] [Related]
17. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis.
McGraw TP; Swanborg RH
Eur J Immunol; 1978 Dec; 8(12):905-9. PubMed ID: 365547
[TBL] [Abstract][Full Text] [Related]
19. Mannosylated self-peptide inhibits the development of experimental autoimmune encephalomyelitis via expansion of nonencephalitogenic T cells.
Kel JM; Slütter B; Drijfhout JW; Koning F; Nagelkerken L
J Leukoc Biol; 2008 Jul; 84(1):182-90. PubMed ID: 18424662
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines.
Ben-Nun A; Cohen IR
J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
